title: Epinephrine inhibits exogenous glucose utilization in exercising horses.
abstract: This study examined the effects of preexercise glucose administration, with and without epinephrine infusion, on carbohydrate metabolism in horses during exercise. Six horses completed 60 min of treadmill exercise at 55 +/- 1% maximum O(2) uptake 1) 1 h after oral administration of glucose (2 g/kg; G trial); 2) 1 h after oral glucose and with an intravenous infusion of epinephrine (0.2 micromol. kg(-1). min(-1); GE trial) during exercise, and 3) 1 h after water only (F trial). Glucose administration (G and GE) caused hyperinsulinemia and hyperglycemia ( approximately 8 mM). In GE, plasma epinephrine concentrations were three- to fourfold higher than in the other trials. Compared with F, the glucose rate of appearance was approximately 50% and approximately 33% higher in G and GE, respectively, during exercise. The glucose rate of disappearance was approximately 100% higher in G than in F, but epinephrine infusion completely inhibited the increase in glucose uptake associated with glucose administration. Muscle glycogen utilization was higher in GE [349 +/- 44 mmol/kg dry muscle (dm)] than in F (218 +/- 28 mmol/kg dm) and G (201 +/- 35 mmol/kg dm). We conclude that 1) preexercise glucose augments utilization of plasma glucose in horses during moderate-intensity exercise but does not alter muscle glycogen usage and 2) increased circulating epinephrine inhibits the increase in glucose rate of disappearance associated with preexercise glucose administration and increases reliance on muscle glycogen for energy transduction.
authors.affiliation: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio 43210, USA. rgeor@ker.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Geor
authors.forename: K W
authors.initials: KW
authors.lastname: Hinchcliff
authors.forename: L J
authors.initials: LJ
authors.lastname: McCutcheon
authors.forename: R A
authors.initials: RA
authors.lastname: Sams
mesh_terms: D000322:Adrenergic Agonists / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D004837:Epinephrine / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005990:Glycerol / Q000097:blood; D006003:Glycogen / Q000378:metabolism; D006029:Glycosuria / Q000652:urine; D006400:Hematocrit; D006736:Horses / Q000378:metabolism / Q000502:physiology*; D007328:Insulin / Q000097:blood; D019344:Lactic Acid / Q000097:blood / Q000378:metabolism; D009043:Motor Activity / Q000502:physiology*; D018482:Muscle, Skeletal / Q000378:metabolism; D009994:Osmolar Concentration; D011659:Pulmonary Gas Exchange
chemical_list: D000322:Adrenergic Agonists; D001786:Blood Glucose; D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D019344:Lactic Acid; D006003:Glycogen; D005947:Glucose; D005990:Glycerol; D004837:Epinephrine